Tanaffos最新文献_第3页

Light-Based Therapy: Novel Approach to Treat COVID-19. 光基疗法：治疗 COVID-19 的新方法。

Tanaffos Pub Date : 2023-03-01

Seyedeh Sara Azadeh, Gholamreza Esmaeeli Djavid, Sima Nobari, Hoda Keshmiri Neghab, Motahareh Rezvan

引用次数: 0

Efficiency of an Online Intervention in the Knowledge Concerning COPD in Nursing Students. 在线干预对护理专业学生了解慢性阻塞性肺病知识的效率。

Tanaffos Pub Date : 2023-03-01

Evangelos C Fradelos, Ioannis C Lampropoulos, Dimitrios G Raptis, Dimitrios Mantzaris, Ioanna V Papathanasiou, Zoe Daniil, Konstantinos I Gourgoulianis, Foteini Malli

{"title":"Efficiency of an Online Intervention in the Knowledge Concerning COPD in Nursing Students.","authors":"Evangelos C Fradelos, Ioannis C Lampropoulos, Dimitrios G Raptis, Dimitrios Mantzaris, Ioanna V Papathanasiou, Zoe Daniil, Konstantinos I Gourgoulianis, Foteini Malli","doi":"","DOIUrl":"","url":null,"abstract":"Background: Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating respiratory disorder. Nurses play a major role in managing the disease. This study aimed to test the effect of a brief online intervention in increasing the knowledge of COPD in a sample of nursing students in Greece.Materials and methods: The intervention entailed a combination of two ½ hour lectures focusing on the treatment and care of patients with COPD according to existing guidelines. Data were collected with a structured questionnaire specially designed for this study including questions regarding information on sociodemographic characteristics of the participants, and the Bristol COPD Knowledge Questionnaire (BCKQ) which is designed to assess the knowledge of 13 COPD-specific topics. The questionnaire was distributed three times and the one-way ANOVA test of repeated measures was applied to investigate the effect of the educational intervention by examining the periods before, immediately after, and one month after the intervention.Results: 125 nursing students participated in this study of which 13.6% were men (n=17) and 86.4% were women. According to the results of the repeated measures ANOVA test, there was a statistically significant improvement in gained knowledge about COPD.Conclusions: Short educational interventions can be effective in acquiring and cultivating nursing students concerning COPD. These short online tutorials seem to be cost-effective as they can be organized easily and with minimal financial resources.","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022201/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Inflammatory Serum Biomarker Pattern in Emphysema and Chronic Bronchitis Phenotypes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. 慢性阻塞性肺病急性加重期肺气肿和慢性支气管炎表型的炎症血清生物标志物模式

Tanaffos Pub Date : 2023-03-01

Maryam Edalatifard, Esmaeil Mortaz, Fariba Ghorbani, Besharat Rahimi, Seyed Mehran Marashian, Roshan Dinparastisaleh, Fatemeh Yassari, Alireza Eslaminejad

{"title":"Inflammatory Serum Biomarker Pattern in Emphysema and Chronic Bronchitis Phenotypes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.","authors":"Maryam Edalatifard, Esmaeil Mortaz, Fariba Ghorbani, Besharat Rahimi, Seyed Mehran Marashian, Roshan Dinparastisaleh, Fatemeh Yassari, Alireza Eslaminejad","doi":"","DOIUrl":"","url":null,"abstract":"Background: COPD exacerbation is characterized by both airway and systemic inflammation. The present study aimed to investigate the relationship between serum levels of some inflammatory biomarkers and the phenotypes of COPD exacerbation.Materials and methods: This study includes known COPD patients, presenting to a hospital with acute exacerbation of COPD. Serum levels of CRP, ESR, CBC, TNF-α, IL-8, and IL-6 were measured at the time of admission. According to the previously done HRCT, the patients were divided into two groups including emphysema and chronic bronchitis. Levels of serum biomarkers were compared in the two groups. The relationships between biomarkers and duration of hospitalization were assessed too.Results: Comparison of quantitative CRP levels, WBC, and platelet counts did not show a statistically significant difference between emphysema and chronic bronchitis but it was significantly higher than control subjects. Although not statistically significant, ESR level was higher in emphysema. TNF-alpha was 6.0±1.5 ng / ml and 1.5 ng / ml in the emphysema and chronic bronchitis groups, respectively. TNF-α had no significant difference compared to the groups. Although higher than the control group, IL-6 and IL-8 did not show significant differences between emphysema and chronic bronchitis. The two groups did not statistically differ in terms of hospital stay but patients with higher serum TNF-α tended to have longer hospitalization and ICU admission.Conclusion: The present study showed predictably higher inflammatory biomarkers in COPD exacerbation but no significant difference between the two phenotypes of COPD and these two entities could not be discriminated based on inflammatory bio-factors.","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Remdesivir in Patients with Advanced Renal Failure and COVID-19. 雷米替韦在晚期肾衰竭患者中的应用和 COVID-19。

Tanaffos Pub Date : 2023-03-01

Fatemeh Yassari, Maryam Sadat Mirenayat, Atefeh Fakharian, Farin Rashid Farokhi, Parisa Honarpisheh

引用次数: 0

Parietal Pleural Lymphatic Blockage by Anthracotic Nodule Laden Macrophage, Leading Cause of Pleural Effusion in Anthracosis. 顶叶胸膜淋巴管被炭疽结节中的巨噬细胞阻塞，这是炭疽病胸腔积液的主要原因。

Tanaffos Pub Date : 2023-03-01

Majid Mirsadraee

引用次数: 0

A Rare Case of Pulmonary Hypertension, Misdiagnosed as Interstitial Lung Disease: Pulmonary Capillary Hemangiomatosis. 一个被误诊为间质性肺病的罕见肺动脉高压病例：肺毛细血管血管瘤病。

Tanaffos Pub Date : 2023-03-01

Parisa Adimi, Majid Malekmohammad, Mihan Pourabdollah, Farah Naghashzadeh

引用次数: 0

Comparing the Effect of Respiratory Physiotherapy and Positive End-Expiratory Pressure Changes on Capnography Results in Intensive Care Unit Patients with Ventilator-Associated Pneumonia. 比较呼吸理疗和呼气末正压变化对重症监护病房呼吸机相关肺炎患者血气分析结果的影响

Tanaffos Pub Date : 2023-03-01

Morteza Shahrokhi, Mohammad Gholizadeh Gerdrodbari, Seyyed Mohamad Mousavi, Sedighe Rastaghi, Farzaneh Enayati

{"title":"Comparing the Effect of Respiratory Physiotherapy and Positive End-Expiratory Pressure Changes on Capnography Results in Intensive Care Unit Patients with Ventilator-Associated Pneumonia.","authors":"Morteza Shahrokhi, Mohammad Gholizadeh Gerdrodbari, Seyyed Mohamad Mousavi, Sedighe Rastaghi, Farzaneh Enayati","doi":"","DOIUrl":"","url":null,"abstract":"Background: While critically ill patients experience a life-threatening illness, they commonly develop ventilator-associated pneumonia (VAP) which can increase morbidity, mortality, and healthcare costs. The present study aimed to compare the effect of respiratory physiotherapy and increased positive endexpiratory pressure (PEEP) on capnography results.Materials and methods: This randomized control clinical trial was performed on 80 adult patients with VAP in the intensive care unit (ICU). The patients were randomized to receive either PEEP at 5 cm H2O, followed by a moderate increase in PEEP to 10 cm H2O, or PEEP at 5 cm H2O with respiratory physiotherapy for 15 min. The numerical values were recorded on the capnograph at minutes 1, 5, 10, 15, and 30 in both methods. Data collection instruments included a checklist and MASIMO capnograph.Results: As evidenced by the obtained results, the two methods significantly differed in the excreted pCO2 (partial pressure of carbon dioxide) (P<0.0001). However, the average amount of excreted pCO2 was higher in the respiratory physiotherapy and PEEP intervention (38.151mmHg) in comparison with increasing PEEP alone method (36.184mmHg). Also, PEEP elevation method prolonged the time of the first phase (inhalation time) and the second phase while shortening the third phase (exhalation time) in capnography waves.Conclusion: CO2 excretion in patients with VAP increased after respiratory physiotherapy. Further, physiotherapy demonstrated more acceptable results in CO2 excretion compared with PEEP changes in mechanically ventilated patients.","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140858066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Fatal Large Intracardiac in Situ Thrombus in a Mildly Symptomatic COVID-19 Patient: A Case Report. 一名症状轻微的 COVID-19 患者体内致命的大型原位心内血栓：病例报告。

Tanaffos Pub Date : 2023-02-01

Neda Behzadnia, Farah Naghashzadeh, Mohammad-Sadegh Keshmiri

{"title":"Fatal Large Intracardiac in Situ Thrombus in a Mildly Symptomatic COVID-19 Patient: A Case Report.","authors":"Neda Behzadnia, Farah Naghashzadeh, Mohammad-Sadegh Keshmiri","doi":"","DOIUrl":"","url":null,"abstract":"Background: The coronavirus disease 2019 (COVID-19) has caused a global pandemic with a significant negative impact on health worldwide. Although it primarily involves the respiratory tract system, cardiovascular complications, particularly thrombotic events are increasingly reported and are associated with adverse outcomes.Case summary: We describe a 30-year-old male who presented with exaggerated dyspnea and hypoxia with mild constitutional symptoms along with a positive PCR test for SARS-CoV-2. He was a known case of bronchiectasis and large bullae in the left lung. Transthoracic echocardiography showed a large right ventricle (RV) mass entrapped within RV papillary muscles and apex. Cardiac MRI was suggestive of RV thrombosis. Regarding diffuse underlying lung disease and improving respiratory symptoms with COVID-19 negative PCR test, we decided to prescribe anticoagulation with heparin infusion and then oral anticoagulant with Rivaroxaban 20 mg daily and follow up after 30 days. Unfortunately, the patient died after 2 weeks in his hometown.Conclusion: Thrombotic complications are frequently encountered in COVID-19 patients. We report a fatal case of large intracardiac thrombus associated with SARS-CoV-2 infection managed with anticoagulant therapy with a catastrophic outcome.","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140869472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cardiopulmonary Exercise Test Parameters among Dialysis Patients with End-Stage Renal Disease. 终末期肾病透析患者的心肺运动测试参数

Tanaffos Pub Date : 2023-02-01

Alireza Eslaminejad, Seyed Mehran Marashian, Mohammad Hadi Tajik Jalayeri, Fatemeh Yassari

{"title":"Cardiopulmonary Exercise Test Parameters among Dialysis Patients with End-Stage Renal Disease.","authors":"Alireza Eslaminejad, Seyed Mehran Marashian, Mohammad Hadi Tajik Jalayeri, Fatemeh Yassari","doi":"","DOIUrl":"","url":null,"abstract":"Background: The current study aimed to assess some parameters of the cardiopulmonary exercise test (CPET) among end-stage renal disease patients who underwent dialysis. The ultimate goal is to improve disease management to achieve optimal quality of life and exercise capacity in this group of patients.Materials and methods: Through a cross-sectional design, the current study enrolled 46 dialysis patients by simple sampling between Jan 2019 and Jan 2020. Some CPET parameters such as AT, VO2, VO2/kg, SPO2, minute ventilation CO2 production/O2 consumption ratios (VE/VCO2 and VE/VO2, respectively), O2 pulse, heart rate reserve (HRR), breathing reserve (BR) and end-tidal carbon dioxide pressure (PETCO2) were focused.Results: Although a limited sample size, the current study showed that VO2/Kg, VE/VCO2, PETCO2, and SPO2 are the main parameters affected by dialysis as expected.Conclusion: The current study suggests using cardiopulmonary rehabilitation for all chronic medical conditions such as chronic kidney disease and end-stage renal disease that increase the rate of metabolic acidosis.","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effects of Probiotics on Clinical Manifestations of Bronchiectasis: A Randomized, Triple Blinded, Placebo-Controlled Clinical Trial. 益生菌对支气管扩张症临床表现的影响：随机、三盲、安慰剂对照临床试验。

Tanaffos Pub Date : 2023-02-01

Ali Alavi Foumani, Alireza Jafari, Azita Tangestani Nejad, Alireza Jafarinejhad, Shabnam Ziyapour, Mohammad Hossein Keivanlou, Masoumeh Afzalipour

{"title":"Effects of Probiotics on Clinical Manifestations of Bronchiectasis: A Randomized, Triple Blinded, Placebo-Controlled Clinical Trial.","authors":"Ali Alavi Foumani, Alireza Jafari, Azita Tangestani Nejad, Alireza Jafarinejhad, Shabnam Ziyapour, Mohammad Hossein Keivanlou, Masoumeh Afzalipour","doi":"","DOIUrl":"","url":null,"abstract":"Background: Bronchiectasis is a condition characterized by abnormal and permanent bronchial constriction that leads to sputum production and bronchial infection. The current study was done to evaluate the effects of symbiotic probiotics on the clinical manifestations and exacerbation of bronchiectasis.Materials and methods: 26 patients in the placebo group (A) and 24 patients in the probiotic group (B) were allocated. In group A, patients took the placebo capsules two times daily for six months. In group B, patients took the LactoCare two times daily for six months.Results: The mean age of patients was 55.73±13.62 (group A) and 54.5±12.59 years (group B). Most of the patients had consumed azithromycin in both groups. The current study demonstrated there was no statistically significant difference between the decreased rate of pulmonary exacerbations in both groups. However, a decreasing trend was shown in the rate of pulmonary exacerbations without hospitalization (P=0.610). Also, there was a decreasing trend in the rate of pulmonary exacerbations leading to hospitalization (P=0.956). The most frequent etiologic pathogen was Pseudomonas sp. FEV1 and FVC/FEV1 ratios were higher in group B than in group A. However, there was no statistically significant difference between groups A and B (P=0.908 vs 0.403).Conclusion: The symbiotic probiotics were not effective in the clinical improvement of bronchiectasis, consumption of antibiotics, the rate of pulmonary exacerbations with or without hospitalization, FEV1 and FEV1/FVC, and microbiological pattern.","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016918/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0